Company History
Company strategy
Work with us
Licenced partners
Corporate Governance
Management team
Board of directors
General meetings
Financial reports
About Gerd
Patient Story - Life with GERD
Patient Story - Everyday life with GERD
Linaprazan glurate
PPIs versus P-CABs
Development strategy
Clinical development
Corporate Governance Reports
General Meetings
2022
The work of the board
Board committees
Management
Nomination Committee
Remuneration
Auditing
Articles of Association
The Share
Ownership
Reports & Presentations
Interim Reports
Annual Reports
Presentations
IPO
Press releases
Calendar
News
Subscribe
Media gallery
People
Logotypes
Notice of EGM December 2022 (sv. kallelse)
Power of attorney form (sv. fullmaktsformulär)
Advance voting form (sv. förhandsröstningsformulär)
The Board of Director's Report, Swedish Companies Act 14:8 (sv. styrelseredogörelse ABL 14 kap 8 §)
Auditor's Statement, Swedish Companies Act 14:8 (sv. revisorsyttrande enligt ABL 14 kap 8 §)
Terms and Conditions for Cinclus Pharma Holding (publ)’s warrants under QESO 2022 (sv. Teckningsoptionsvillkor)